PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.160
-0.060 (-1.42%)
Feb 27, 2026, 10:27 AM EST - Market open
PolyPid Market Cap
PolyPid has a market cap or net worth of $75.73 million as of February 27, 2026. Its market cap has increased by 262.57% in one year.
Market Cap
75.73M
Enterprise Value
66.68M
1-Year Change
262.57%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $75.73M, a decrease of -8.13%. That is a compound annual growth rate of -1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 78.10M | 8.17% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 80.33M |
| Pliant Therapeutics | 79.27M |
| Pelthos Therapeutics | 75.71M |
| MediciNova | 74.82M |
| eXoZymes | 74.76M |
| Adicet Bio | 73.98M |
| Annovis Bio | 73.41M |
| PMV Pharmaceuticals | 72.90M |